3979 related articles for article (PubMed ID: 2777216)
1. Basement membrane deposition in benign and malignant naevo-melanocytic lesions: an immunohistochemical study with antibodies to type IV collagen and laminin.
Havenith MG; van Zandvoort EH; Cleutjens JP; Bosman FT
Histopathology; 1989 Aug; 15(2):137-46. PubMed ID: 2777216
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of basement membranes in pigment cell tumors of the skin, relation to cell type and clinical behavior.
Stenbäck F; Wasenius VM
J Cutan Pathol; 1986 Jun; 13(3):175-86. PubMed ID: 3525624
[TBL] [Abstract][Full Text] [Related]
3. Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy.
Schaumburg-Lever G; Lever I; Fehrenbacher B; Möller H; Bischof B; Kaiserling E; Garbe C; Rassner G
J Cutan Pathol; 2000 Feb; 27(2):67-75. PubMed ID: 10678701
[TBL] [Abstract][Full Text] [Related]
4. Distribution of laminin and collagen type-IV in benign and malignant lesions of melanocytic origin.
Natali PG; Nicotra MR; Bellocci M; Cavaliere R; Bigotti A
Int J Cancer; 1985 Apr; 35(4):461-7. PubMed ID: 3886560
[TBL] [Abstract][Full Text] [Related]
5. Identification of basement membrane components in eosinophilic globules in a case of Spitz's nevus.
Schmoeckel C; Stolz W; Burgeson R; Krieg T
Am J Dermatopathol; 1990 Jun; 12(3):272-4. PubMed ID: 1693820
[TBL] [Abstract][Full Text] [Related]
6. Structure of basement membranes in malignant melanoma and nevocytic nevi.
Schmoeckel C; Stolz W; Sakai LY; Burgeson RE; Timpl R; Krieg T
J Invest Dermatol; 1989 May; 92(5):663-8. PubMed ID: 2497191
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical investigation of alpha1 (IV) and alpha5 (IV) collagen chains in a broad spectrum of melanocytic tumours.
Quatresooz P; Piérard GE
Melanoma Res; 2005 Jun; 15(3):161-8. PubMed ID: 15917697
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
9. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
Rose DS
J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies comparing the localization of type XV collagen in normal human skin and skin tumors with that of type IV collagen.
Fukushige T; Kanekura T; Ohuchi E; Shinya T; Kanzaki T
J Dermatol; 2005 Feb; 32(2):74-83. PubMed ID: 15906535
[TBL] [Abstract][Full Text] [Related]
11. The extracellular matrix in pigmented skin lesions: an immunohistochemical study.
Van Duinen CM; Fleuren GJ; Bruijn JA
Histopathology; 1994 Jan; 24(1):33-40. PubMed ID: 7511560
[TBL] [Abstract][Full Text] [Related]
12. Type IV collagen and laminin staining patterns in benign and malignant cutaneous lesions.
Mackie RM; Clelland DB; Skerrow CJ
J Clin Pathol; 1989 Nov; 42(11):1173-7. PubMed ID: 2479664
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
14. Expression of basement membrane antigens in spindle cell melanoma.
Prieto VG; Woodruff JM
J Cutan Pathol; 1998 Jul; 25(6):297-300. PubMed ID: 9694618
[TBL] [Abstract][Full Text] [Related]
15. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
Pisacane AM; Risio M
Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
17. Expression of two morphologic parameters concerning tumor-stroma interaction in benign and malignant melanocytic skin lesions.
Fink-Puches R; Smolle J; Hofmann-Wellenhof R; Kerl H
Am J Dermatopathol; 1998 Oct; 20(5):468-72. PubMed ID: 9790107
[TBL] [Abstract][Full Text] [Related]
18. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
Schmid P; Itin P; Rufli T
Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
[TBL] [Abstract][Full Text] [Related]
19. Basement membrane in Kaposi's sarcoma: an immunohistochemical and ultrastructural study.
Bendelac A; Kanitakis J; Chouvet B; Thivolet J
Pathol Res Pract; 1985 Dec; 180(6):626-32. PubMed ID: 3913949
[TBL] [Abstract][Full Text] [Related]
20. Expression of endoglin in human melanocytic lesions.
Dawn G; MacKie RM
Clin Exp Dermatol; 2002 Mar; 27(2):153-6. PubMed ID: 11952710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
